0001950047-24-004980.txt : 20240624 0001950047-24-004980.hdr.sgml : 20240624 20240624161908 ACCESSION NUMBER: 0001950047-24-004980 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240624 DATE AS OF CHANGE: 20240624 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc. CENTRAL INDEX KEY: 0000873303 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 930797222 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-14895 FILM NUMBER: 241064505 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-274-4000 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Sarepta Therapuetics, Inc. DATE OF NAME CHANGE: 20120712 FORMER COMPANY: FORMER CONFORMED NAME: AVI BIOPHARMA INC DATE OF NAME CHANGE: 19980930 FORMER COMPANY: FORMER CONFORMED NAME: ANTIVIRALS INC DATE OF NAME CHANGE: 19970123 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Arif Bilal CENTRAL INDEX KEY: 0001959750 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 215 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02129 144 1 primary_doc.xml 144 0001959750 XXXXXXXX LIVE 0000873303 SAREPTA THERAPEUTICS INC 001-14895 215 First Street Suite 415 Cambridge MA 02142 617-274-4000 BILAL ARIF Officer COMMON Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 8th Floor New York NY 10004

7859 1263098.48 94523766 06/24/2024 NASDAQ Common 02/28/2020 Employee Stock Purchase Plan Issuer N 933 02/28/2020 Cash Common 03/29/2020 Restricted Stock Units Issuer N 6926 03/29/2020 N/A Y The securities to be sold were acquired upon the vesting of restricted stock units during the period of 03/29/2020 through 03/07/2024. 06/24/2024 03/11/2024 /s/ Bilal Arif